Immunosurveillance has been demonstrated in the Vk∗MYC mouse model, where immune control of MM was demonstrated via NK and CD8+ T cells through CD226 (DNAM-1) interaction with its ligand CD155 on malignant plasma cells [23]. This evidence concerns the gene CD8A and Miyoshi myopathy.